Nosratollah Zarghami

17.9k total citations · 3 hit papers
375 papers, 13.8k citations indexed

About

Nosratollah Zarghami is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Nosratollah Zarghami has authored 375 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Molecular Biology, 67 papers in Biomaterials and 53 papers in Cancer Research. Recurrent topics in Nosratollah Zarghami's work include Curcumin's Biomedical Applications (36 papers), RNA Interference and Gene Delivery (34 papers) and Nanoparticle-Based Drug Delivery (33 papers). Nosratollah Zarghami is often cited by papers focused on Curcumin's Biomedical Applications (36 papers), RNA Interference and Gene Delivery (34 papers) and Nanoparticle-Based Drug Delivery (33 papers). Nosratollah Zarghami collaborates with scholars based in Iran, Türkiye and United States. Nosratollah Zarghami's co-authors include Abolfazl Akbarzadeh, Younes Pilehvar‐Soltanahmadi, Mohammad Kouhi, Kazem Nejati‐Koshki, Younes Hanifehpour, Sang Woo Joo, Soodabeh Davaran, Mohammad Samiei, Mehdi Dadashpour and Hadis Daraee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Analytical Biochemistry.

In The Last Decade

Nosratollah Zarghami

363 papers receiving 13.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liposome: classification, preparation, and applications

2013 2.5k citations Abolfazl Akbarzadeh, Nosratollah Zarghami et al. profile →
Carbon nanotubes: properties, synthesis, purification, and medical applications

2014 793 citations Nosratollah Zarghami, Abolfazl Akbarzadeh et al. profile →
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems

2014 416 citations Kazem Nejati‐Koshki, Abolfazl Akbarzadeh et al. profile →

Peers

Countries citing papers authored by Nosratollah Zarghami

Since Specialization

Citations

This map shows the geographic impact of Nosratollah Zarghami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nosratollah Zarghami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nosratollah Zarghami more than expected).

Fields of papers citing papers by Nosratollah Zarghami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nosratollah Zarghami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nosratollah Zarghami. The network helps show where Nosratollah Zarghami may publish in the future.

Co-authorship network of co-authors of Nosratollah Zarghami

This figure shows the co-authorship network connecting the top 25 collaborators of Nosratollah Zarghami. A scholar is included among the top collaborators of Nosratollah Zarghami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nosratollah Zarghami. Nosratollah Zarghami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An update on experimental to large-scale production of bacteriophages against superbugs: a review 2025 ·Critical Reviews in Biotechnology ·(unknown), (unknown), (unknown), (unknown), Nosratollah Zarghami	0
2	Sodium alginate hydrogels co-encapsulated with cell free fat extract-loaded core-shell nanofibers and menstrual blood stem cells derived exosomes for acceleration of articular cartilage regeneration 2024 ·International Journal of Biological Macromolecules ·Hongtao Zhang, (unknown), Qiong Ma, Lin Li, Younes Pilehvar‐Soltanahmadi, Nosratollah Zarghami, (unknown), Kui Xu, (unknown), Kang Yan, Hua Long, (unknown)	5
3	Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells 2024 ·DARU Journal of Pharmaceutical Sciences ·(unknown), Davoud Jafari-Gharabaghlou, (unknown), (unknown), (unknown), Nosratollah Zarghami	4
4	Stimulus-responsive nanocarrier from star-shaped polyethyleneimine-β-cyclodextrin coated mesoporous silica for targeted combination cancer therapy 2023 ·Journal of Drug Delivery Science and Technology ·Hanieh Mousazadeh, (unknown), Nosratollah Zarghami	5
5	Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells 2023 ·Frontiers in Oncology ·(unknown), Davoud Jafari-Gharabaghlou, (unknown), Nosratollah Zarghami	15
6	Strategies for Isothermal Amplification of Nucleic Acids: are they Ready to be Applied in Point of Care Diagnosis of Mycosis? 2020 ·Biointerface Research in Applied Chemistry ·(unknown), Hamed Fakhim, Afsane Vaezi, Mohammad Pourhassan‐Moghaddam, Abbas Ebrahimi‐Kalan, Nosratollah Zarghami, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
7	Fluorescence Intensity Enhancement of Green Carbon Dots: Synthesis, Characterization and Cell Imaging 2020 ·Photochemistry and Photobiology ·Fatemeh Hashemi, Fatemeh Heidari, (unknown), Farideh Mahmoodzadeh, Nosratollah Zarghami	22
8	Synthesis, characterisation, and application of chamomile gold nanoparticles in molecular diagnostics: a new component for PCR kits 2019 ·Biointerface Research in Applied Chemistry ·(unknown), Mohammad Pourhassan‐Moghaddam, Abbas Karimi, Abolfazl Akbarzadeh, Nosratollah Zarghami, Seyed Abolghasem Mohammadi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	9
9	Apelin-13 serum levels in type 2 diabetic obese women: possible relations with microRNAs-107 and 375 2018 ·Turkish Journal of Biochemistry ·(unknown), Mohammad Rahmati‐Yamchi, Alireza Ostadrahimi, (unknown), Majid Mobasseri, Salar Bakhtiyari, Nosratollah Zarghami	5
10	Tuning of major signaling networks (TGF-β, Wnt, Notch and Hedgehog) by miRNAs in human stem cells commitment to different lineages: Possible clinical application 2017 ·Biomedicine & Pharmacotherapy ·Sedigheh Fekri Aval, Hajie Lotfi, Roghayeh Sheervalilou, Nosratollah Zarghami	33
11	Investigating the effects of Lactobacillus casei on some biochemical parameters in diabetic mice 2017 ·Journal of Endocrinology Metabolism and Diabetes of South Africa ·(unknown), Asghar Tanomand, (unknown), (unknown), Nosratollah Zarghami	6
12	Gold nanoprobe-based method for sensing activated leukocyte cell adhesion molecule (ALCAM) gene expression, as a breast cancer biomarker 2016 ·Artificial Cells Nanomedicine and Biotechnology ·(unknown), Abolfazl Akbarzadeh, Nosratollah Zarghami, Mohammad Rahmati‐Yamchi	5
13	Synergistic Effects of Chrysin-Curcumin Loaded in PLGA-PEG Nanoparticles on Inhibiting Breast Cancer Cell Line Growth 2015 ·Nosratollah Zarghami, (unknown), Azim Akbarzadeh, Younes Pilehvar‐Soltanahmadi, Faraz Zarghami	1
14	The effect of Dimethyl Sulfoxide on hepatogenic differentiation of Mesenchymal Stem Cells 2014 ·SHILAP Revista de lepidopterología ·Effat Alizadeh, Nosratollah Zarghami, Mohamadreza Baghaban Eslaminejad, Abolfazl Akbarzadeh, (unknown), Abolfazl Barzegar, (unknown), Seyed Abolghasem Mohammadi	4
15	Adiponectin Can Affect ER Signaling in Obese Breast Cancer Patients 2012 ·Journal of Cancer Therapy ·Rana Jahanban‐Esfahlan, Nosratollah Zarghami, (unknown), (unknown), Maryam Daneshvar, Ali Jahanban‐Esfahlan, Majid Mobasseri, Kazem Nejati‐Koshki	8
16	Inhibitory Effect Of Zinc, Copper And Selenium On Telomerase Activity In Tumor Tissues And T47D Breast Cancer Cell Line 2011 ·SHILAP Revista de lepidopterología ·Nosratollah Zarghami, Mohammad Rahmati, (unknown), Mohammad Pourhassan‐Moghaddam, Jahanbakhsh Asadi	1
17	Hypoadiponectinemia in obese subjects with type II diabetes: A close association with central obesity indices 2011 ·SHILAP Revista de lepidopterología ·Ghorban Mohammadzadeh, Nosratollah Zarghami	12
18	Quantification of Steroid Receptors Gene Expression in Breast Cancer Patients: Possible Correlation with Serum Level of Adipocytokines 2011 ·Journal of Cancer Therapy ·Rana Jahanban‐Esfahlan, Nosratollah Zarghami, (unknown), Amir Monfaredan, (unknown), Ali Jahanban‐Esfahlan, (unknown), (unknown), (unknown), Majid Mobasseri	12
19	PREVALENCE OF LOW BACK PAIN AMONG WOMEN OF FERTILITY AGE IN TABRIZ AND THE RELATED RISK FACTORS 2008 ·Medical Journal of Tabriz University of Medical Sciences and Health Services ·(unknown), (unknown), (unknown), (unknown), Nosratollah Zarghami	2
20	Evaluation of Lipid Peroxidation as an Indirect Measure of Oxidative Stress in Seminal Plasma 2004 ·International Journal of Reproductive BioMedicine (IJRM) ·Nosratollah Zarghami, Ali Khosrowbeygi	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact